Actively Recruiting
Translational Neuroscience Study on Memory Deterioration and Brain Changes in Alzheimers Disease
Led by Norwegian University of Science and Technology · Updated on 2026-08-13
30
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to better understand individual differences in patients with Alzheimers disease, focusing on memory deterioration and related neurodegenerative changes. It compares brain and biological changes between patients diagnosed with Alzheimers or mild cognitive impairment and age- and gender-matched healthy controls. The study is sponsored by the Norwegian University of Science and Technology and follows participants over one year. Participants undergo several assessments including advanced 7T MRI scans during rest and memory tasks, resting-state EEG, blood and stool sample collection to analyze biomarkers and gut microbiota, and neuropsychological testing using the MoCA tool. These evaluations are designed to capture detailed brain activity, cognitive function, and biological markers relevant to Alzheimers disease and mild cognitive impairment. During the year-long follow-up, researchers monitor changes in brain structure, cognitive abilities, and biological samples to identify patterns that distinguish dementia patients from healthy individuals. The study tracks progression from mild cognitive impairment to Alzheimers disease and uses these data to better understand disease mechanisms. Participants live at home and attend scheduled assessments without receiving experimental treatments.
CONDITIONS
Brief Title
Memory Deterioration in Alzheimer Disease
Research Team
A
Axel Sandvig Professor, MD & PhD
V
Varanann Varathalingam
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here